154 related articles for article (PubMed ID: 3780835)
1. Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.
Ambroes Y; Ronflette I; Dodion L
Eur J Clin Pharmacol; 1986; 31 Suppl():1-7. PubMed ID: 3780835
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Dodion L; Ambroes Y; Lameire N
Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
[TBL] [Abstract][Full Text] [Related]
3. Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.
Lambe R; Kennedy O; Kenny M; Darragh A
Eur J Clin Pharmacol; 1986; 31 Suppl():9-14. PubMed ID: 3780841
[TBL] [Abstract][Full Text] [Related]
4. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
5. Dose-response curve for torasemide in healthy volunteers.
Scheen AJ
Arzneimittelforschung; 1988 Jan; 38(1A):156-9. PubMed ID: 3370061
[TBL] [Abstract][Full Text] [Related]
6. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
[TBL] [Abstract][Full Text] [Related]
7. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.
Boesken WH; Kult J
Clin Nephrol; 1997 Jul; 48(1):22-8. PubMed ID: 9247774
[TBL] [Abstract][Full Text] [Related]
8. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
Knauf H; Mutschler E
Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
[TBL] [Abstract][Full Text] [Related]
9. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.
Lesne M; Clerckx-Braun F; Duhoux P; van Ypersele de Strihou C
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):382-7. PubMed ID: 7118326
[TBL] [Abstract][Full Text] [Related]
11. Acute Pharmacodynamic Effects of Empagliflozin With and Without Diuretic Agents in Patients With Type 2 Diabetes Mellitus.
Heise T; Jordan J; Wanner C; Heer M; Macha S; Mattheus M; Lund SS; Woerle HJ; Broedl UC
Clin Ther; 2016 Oct; 38(10):2248-2264.e5. PubMed ID: 27666126
[TBL] [Abstract][Full Text] [Related]
12. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
van Ganse E; Douchamps J; Deger F; Staroukine M; Verniory A; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():43-7. PubMed ID: 3536531
[TBL] [Abstract][Full Text] [Related]
13. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of torasemide, a new loop diuretic.
Brater DC; Leinfelder J; Anderson SA
Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
[TBL] [Abstract][Full Text] [Related]
15. Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.
Dodion L; Willems JL
Eur J Clin Pharmacol; 1986; 31 Suppl():49-51. PubMed ID: 3780839
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats.
Roche-Catholy M; Paepe D; Devreese M; Broeckx BJG; Woehrlé F; Schneider M; de Salazar Alcala AG; Hellemans A; Smets P
J Vet Intern Med; 2022 Sep; 36(5):1782-1791. PubMed ID: 35906901
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide.
Vormfelde SV; Engelhardt S; Zirk A; Meineke I; Tuchen F; Kirchheiner J; Brockmöller J
Clin Pharmacol Ther; 2004 Dec; 76(6):557-66. PubMed ID: 15592327
[TBL] [Abstract][Full Text] [Related]
19. Short term effects and urinary excretion of the new diuretic, indapamide, in normal subjects.
Campbell DB; Phillips EM
Eur J Clin Pharmacol; 1974 Oct; 7(6):407-14. PubMed ID: 4612998
[No Abstract] [Full Text] [Related]
20. Torasemide. A review of its pharmacological properties and therapeutic potential.
Friedel HA; Buckley MM
Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
